BrainTap's 40Hz Light Claims: What Science Says

There's a headset that flickering light into your eyes and ears, and its creator says it broke up Alzheimer's plaque, fixed coal miners' sleep in three weeks, got 90% of autistic children speaking without speech therapy, and made workers 26% more productive in a single afternoon session.

If that sounds like a lot—it is. But some of it is also grounded in real neuroscience. That tension is exactly what makes BrainTap worth understanding clearly, rather than either dismissing or swallowing whole.

In a recent episode of The Human Upgrade, biohacking entrepreneur Dave Asprey sat down with Dr. Patrick Porter, PhD, the founder of BrainTap, for a conversation that moved fluidly between legitimate research, intriguing mechanisms, and claims that significantly outpace the published evidence. Porter has been in this field since the 1980s, when he was part of the first generation of light-and-sound machine researchers. He's not a fringe figure. But the conversation aired as a promotional episode—Porter is selling a product, Asprey is an affiliate, and the structure of the discussion reflects that reality. Keeping that context visible matters.

The Actual Science Underneath the Claims

Let's start with what's genuinely interesting here, because there is something genuinely interesting here.

The 40Hz gamma frequency research is real and it's compelling. MIT neuroscientist Li-Huei Tsai and her colleagues have published peer-reviewed work—including in Nature—showing that flickering light at 40 times per second can drive gamma oscillations in the brain, reduce amyloid and tau pathology in mouse models of Alzheimer's, and improve cognitive function in those animal studies. Early-phase human trials have followed, with promising but preliminary results. This is legitimate science happening at a serious institution. It is not, however, the same as "100% of dementia patients got off dementia in six weeks"—a claim Porter made in the episode that has no published, independently verified backing that I can locate.

Porter describes the mechanism this way: "Think about gamma like the bass drum to a band. When you get older, that rhythm goes off, and that's part of what happens with dementia and Alzheimer's as well." That's actually a reasonable lay explanation of something researchers call gamma oscillation disruption, which is documented in Alzheimer's pathology. The metaphor holds up better than the outcome claims do.

Binaural beats—playing slightly different tones in each ear so the brain perceives a third "phantom" frequency—also have a legitimate research base, though a modest one. Studies suggest they can influence relaxation, attention, and anxiety, particularly in the alpha and theta ranges. The effect sizes tend to be small to moderate. The mechanism Porter describes (the brain synthesizing the frequency difference, then neurons "following" that frequency) is consistent with the published literature on frequency following response. It's not magic. It's also not nothing.

The vagus nerve piece is worth noting too. Porter mentions that lights in the ear canal are designed to stimulate the vagal nerve, driving a parasympathetic response. Vagus nerve stimulation is an active area of legitimate neuroscience research, particularly for stress regulation and inflammatory conditions. Whether low-level flickering light in the ear canal reliably achieves meaningful vagal activation is a different, open question—but the anatomical logic isn't invented.

Where the Claims Start to Stretch

Here's where I have to be honest about the gap between the framework and the specific numbers.

Porter cited 72 peer-reviewed studies backing the device. That's a large number, and without being able to review the studies directly, it's impossible to evaluate their quality, sample sizes, independence from commercial interest, or publication status. "Peer-reviewed" spans an enormous range—from randomized controlled trials in high-impact journals to small pilot studies in publications that charge authors for access. The number isn't the signal. The methodology is.

The 26% productivity claim from "studies with Google and Microsoft" is mentioned without any published citation. That's not evidence of fabrication, but it's also not publicly verifiable. Corporate wellness pilots are frequently conducted under non-disclosure agreements and never published. They're designed to inform internal decisions, not the scientific record. Treating them as equivalent to peer-reviewed research is a meaningful conflation.

The dementia claim—"we're at over 100 people now and 100% of them got off dementia in six weeks"—is the one that should give any careful reader pause. Not because light therapy can't have real effects on cognition, but because a 100% response rate in any neurological condition would be one of the most significant medical findings in decades. It would be in every major journal. It would be replicating across institutions. The absence of that trail of evidence doesn't prove the claim is wrong, but it does mean it should be held very lightly until it is.

The autism finding—that 90% of autistic children in one study began speaking after six weeks of pulsed light therapy targeting alpha wave production—raises similar questions. There's emerging work connecting alpha oscillations to some features of autism spectrum conditions, but "began speaking" after an intervention is a life-altering outcome claim that demands rigorous documentation, including what population was studied, what "began speaking" was operationalized to mean, and whether the change persisted.

What the Biohacking Frame Does—and Doesn't Do

One thing worth naming is how the biohacking context shapes what's permissible to claim. In clinical medicine, a device making these assertions would require FDA clearance and regulatory evidence. In the wellness and performance optimization space, the evidentiary standard is much lower—a combination of mechanism plausibility, personal testimonials, and selective citation can carry enormous weight with audiences who've already decided mainstream medicine is too conservative.

That's not a simple indictment. Mainstream medicine is often too conservative about emerging technologies. The glymphatic system—the brain's waste-clearance process that Porter mentions—was indeed largely unknown before 2012 and is now one of the most active research areas in neuroscience. The brain's responsiveness to light is genuinely underappreciated in clinical settings. Asprey's framing that "clinical knowledge should be public knowledge" resonates with a real problem in healthcare communication.

But the loosening of evidentiary standards cuts both ways. The same framework that allows early, promising research to reach people who need it also allows overreach—and when the product is being sold directly, the incentive toward overreach is structural, not personal.

What This Actually Means for Your Brain

Porter's broader premise—that many people are operating in dysregulated neurological states driven by poor sleep, chronic stress, and inadequate light exposure—is well-supported. The idea that non-pharmacological interventions can meaningfully shift those states is also well-supported. Meditation, exercise, sleep hygiene, and light exposure all have robust evidence bases for improving cognitive function and emotional regulation.

Whether BrainTap specifically produces the dramatic outcomes Porter describes is a question the current public evidence can't fully answer. The foundational mechanisms are credible. Several individual components (binaural beats, gamma entrainment, circadian light cues) have legitimate research behind them. The specific effect sizes and the extraordinary outcome claims are where the conversation moves beyond what I'd call established science.

That doesn't mean it doesn't work. It means we're not in a position to know how well it works, for whom, and under what conditions—which is almost always the honest answer to "does this biohacking device do what it says?"

The 40Hz research deserves serious attention. The dementia reversal claims deserve serious scrutiny. Both things can be true, and holding them in tension is more useful than collapsing into either pure skepticism or uncritical enthusiasm.

What happens when we apply that same rigor to every technology promising to upgrade our minds—not to dismiss the possibilities, but to actually understand what we're working with?

---

Samir Patel is a licensed clinical social worker (LCSW) and Mental Health & Wellness Correspondent for Buzzrag. He covers the intersection of neuroscience, mental health access, and psychological wellness.